2008 | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2007 | Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2006 | Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2005 | Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2004 | Dec
2008
September
- ImClone/Bristol-Myers Squibb/Merck Serono: Erbitux disappoints in lung cancer
- UCB: Vimpat offers hope to sufferers of uncontrolled epilepsy
- Pfizer and Medivation: Dimebon co-development agreement
- Is cost containment impacting pharmaceutical innovation?
- Anti-TNFs: FDA calls for additional warnings on blockbuster class
2008 | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2007 | Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2006 | Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2005 | Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2004 | Dec
back to top